http://pharma-marketer.brollyclient.ca Conference-quality resources and connections without the travel Wed, 17 Mar 2010 23:45:19 +0000 http://wordpress.org/?v=2.7.1 en hourly 1 http://pharma-marketer.brollyclient.ca/more/pharma-ads/arimidex-%e2%80%93-crossroads http://pharma-marketer.brollyclient.ca/more/pharma-ads/arimidex-%e2%80%93-crossroads#comments Wed, 17 Mar 2010 23:45:19 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/arimidex-%e2%80%93-crossroads http://pharma-marketer.brollyclient.ca/more/pharma-ads/arimidex-%e2%80%93-crossroads/feed http://pharma-marketer.brollyclient.ca/news-2/astellas-aims-to-take-over-osi-board http://pharma-marketer.brollyclient.ca/news-2/astellas-aims-to-take-over-osi-board#comments Wed, 17 Mar 2010 23:18:16 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/astellas-aims-to-take-over-osi-board http://pharma-marketer.brollyclient.ca/news-2/astellas-aims-to-take-over-osi-board/feed http://pharma-marketer.brollyclient.ca/news-2/three-way-ratiopharm-auction-comes-to-head-sources http://pharma-marketer.brollyclient.ca/news-2/three-way-ratiopharm-auction-comes-to-head-sources#comments Wed, 17 Mar 2010 23:18:15 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/three-way-ratiopharm-auction-comes-to-head-sources http://pharma-marketer.brollyclient.ca/news-2/three-way-ratiopharm-auction-comes-to-head-sources/feed http://pharma-marketer.brollyclient.ca/news-2/abraxis-abraxane-meets-lung-cancer-study-goal http://pharma-marketer.brollyclient.ca/news-2/abraxis-abraxane-meets-lung-cancer-study-goal#comments Wed, 17 Mar 2010 23:18:14 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/abraxis-abraxane-meets-lung-cancer-study-goal http://pharma-marketer.brollyclient.ca/news-2/abraxis-abraxane-meets-lung-cancer-study-goal/feed http://pharma-marketer.brollyclient.ca/news-2/fuzeona%c2%80%c2%99s-fizzle-saps-trimerisa%c2%80%c2%99-earnings http://pharma-marketer.brollyclient.ca/news-2/fuzeona%c2%80%c2%99s-fizzle-saps-trimerisa%c2%80%c2%99-earnings#comments Wed, 17 Mar 2010 23:18:14 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/fuzeona%c2%80%c2%99s-fizzle-saps-trimerisa%c2%80%c2%99-earnings http://pharma-marketer.brollyclient.ca/news-2/fuzeona%c2%80%c2%99s-fizzle-saps-trimerisa%c2%80%c2%99-earnings/feed http://pharma-marketer.brollyclient.ca/news-2/scripts-going-unfilled-at-unprecedented-rate http://pharma-marketer.brollyclient.ca/news-2/scripts-going-unfilled-at-unprecedented-rate#comments Wed, 17 Mar 2010 23:18:13 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/scripts-going-unfilled-at-unprecedented-rate http://pharma-marketer.brollyclient.ca/news-2/scripts-going-unfilled-at-unprecedented-rate/feed http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/more-blogroll http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/more-blogroll#comments Wed, 17 Mar 2010 22:05:35 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/more-blogroll /i> , but it's worth a look. ]]> http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/more-blogroll/feed http://pharma-marketer.brollyclient.ca/more/pharma-ads/nicorette-%e2%80%93-the-most-effective-nicorette-patch-yet http://pharma-marketer.brollyclient.ca/more/pharma-ads/nicorette-%e2%80%93-the-most-effective-nicorette-patch-yet#comments Wed, 17 Mar 2010 22:03:15 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/nicorette-%e2%80%93-the-most-effective-nicorette-patch-yet http://pharma-marketer.brollyclient.ca/more/pharma-ads/nicorette-%e2%80%93-the-most-effective-nicorette-patch-yet/feed http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/dietary-supplements-charted http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/dietary-supplements-charted#comments Wed, 17 Mar 2010 21:59:08 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/dietary-supplements-charted http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/dietary-supplements-charted/feed http://pharma-marketer.brollyclient.ca/internet-marketing/novartis-proposes-use-of-unique-fda-approved-short-urls-hashtags-to-overcome-space-limitation-issues-of-social-media http://pharma-marketer.brollyclient.ca/internet-marketing/novartis-proposes-use-of-unique-fda-approved-short-urls-hashtags-to-overcome-space-limitation-issues-of-social-media#comments Wed, 17 Mar 2010 21:01:29 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/novartis-proposes-use-of-unique-fda-approved-short-urls-hashtags-to-overcome-space-limitation-issues-of-social-media http://pharma-marketer.brollyclient.ca/internet-marketing/novartis-proposes-use-of-unique-fda-approved-short-urls-hashtags-to-overcome-space-limitation-issues-of-social-media/feed http://pharma-marketer.brollyclient.ca/more/pharma-ads/lilly-%e2%80%93-taking-a-closer-look-at-type-2-diabetes http://pharma-marketer.brollyclient.ca/more/pharma-ads/lilly-%e2%80%93-taking-a-closer-look-at-type-2-diabetes#comments Wed, 17 Mar 2010 20:02:56 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/lilly-%e2%80%93-taking-a-closer-look-at-type-2-diabetes http://pharma-marketer.brollyclient.ca/more/pharma-ads/lilly-%e2%80%93-taking-a-closer-look-at-type-2-diabetes/feed http://pharma-marketer.brollyclient.ca/news-2/health-care-bill-faces-delay-as-democrats-struggle-with-cbo http://pharma-marketer.brollyclient.ca/news-2/health-care-bill-faces-delay-as-democrats-struggle-with-cbo#comments Wed, 17 Mar 2010 18:26:15 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/health-care-bill-faces-delay-as-democrats-struggle-with-cbo http://pharma-marketer.brollyclient.ca/news-2/health-care-bill-faces-delay-as-democrats-struggle-with-cbo/feed http://pharma-marketer.brollyclient.ca/news-2/sequenom-earnings-now-theres-an-sec-probe-into-a-failed-hostile-bid-too http://pharma-marketer.brollyclient.ca/news-2/sequenom-earnings-now-theres-an-sec-probe-into-a-failed-hostile-bid-too#comments Wed, 17 Mar 2010 18:26:14 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/sequenom-earnings-now-theres-an-sec-probe-into-a-failed-hostile-bid-too http://pharma-marketer.brollyclient.ca/news-2/sequenom-earnings-now-theres-an-sec-probe-into-a-failed-hostile-bid-too/feed http://pharma-marketer.brollyclient.ca/news-2/bristol-combination-diabetes-drug-under-review http://pharma-marketer.brollyclient.ca/news-2/bristol-combination-diabetes-drug-under-review#comments Wed, 17 Mar 2010 18:26:11 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/bristol-combination-diabetes-drug-under-review http://pharma-marketer.brollyclient.ca/news-2/bristol-combination-diabetes-drug-under-review/feed http://pharma-marketer.brollyclient.ca/news-2/king-subsidiary-agrees-to-425m-settlement http://pharma-marketer.brollyclient.ca/news-2/king-subsidiary-agrees-to-425m-settlement#comments Wed, 17 Mar 2010 18:26:11 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/king-subsidiary-agrees-to-425m-settlement http://pharma-marketer.brollyclient.ca/news-2/king-subsidiary-agrees-to-425m-settlement/feed http://pharma-marketer.brollyclient.ca/news-2/abraxis-medicines-co-in-early-spotlight-as-their-shares-rally http://pharma-marketer.brollyclient.ca/news-2/abraxis-medicines-co-in-early-spotlight-as-their-shares-rally#comments Wed, 17 Mar 2010 18:26:10 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/abraxis-medicines-co-in-early-spotlight-as-their-shares-rally http://pharma-marketer.brollyclient.ca/news-2/abraxis-medicines-co-in-early-spotlight-as-their-shares-rally/feed http://pharma-marketer.brollyclient.ca/news-2/biopharma-rd-rises-2-in-09-despite-recession http://pharma-marketer.brollyclient.ca/news-2/biopharma-rd-rises-2-in-09-despite-recession#comments Wed, 17 Mar 2010 18:17:17 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/biopharma-rd-rises-2-in-09-despite-recession http://pharma-marketer.brollyclient.ca/news-2/biopharma-rd-rises-2-in-09-despite-recession/feed http://pharma-marketer.brollyclient.ca/news-2/astellas-tries-board-coup-in-hostile-bid-for-osi http://pharma-marketer.brollyclient.ca/news-2/astellas-tries-board-coup-in-hostile-bid-for-osi#comments Wed, 17 Mar 2010 18:09:26 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/astellas-tries-board-coup-in-hostile-bid-for-osi http://pharma-marketer.brollyclient.ca/news-2/astellas-tries-board-coup-in-hostile-bid-for-osi/feed http://pharma-marketer.brollyclient.ca/more/pharma-ads/lilly-%e2%80%93-she%e2%80%99s-used-to-running-the-show http://pharma-marketer.brollyclient.ca/more/pharma-ads/lilly-%e2%80%93-she%e2%80%99s-used-to-running-the-show#comments Wed, 17 Mar 2010 18:03:10 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/lilly-%e2%80%93-she%e2%80%99s-used-to-running-the-show http://pharma-marketer.brollyclient.ca/more/pharma-ads/lilly-%e2%80%93-she%e2%80%99s-used-to-running-the-show/feed http://pharma-marketer.brollyclient.ca/news-2/unigene-labs-raises-136m-in-debt-restructuring http://pharma-marketer.brollyclient.ca/news-2/unigene-labs-raises-136m-in-debt-restructuring#comments Wed, 17 Mar 2010 17:53:26 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/unigene-labs-raises-136m-in-debt-restructuring http://pharma-marketer.brollyclient.ca/news-2/unigene-labs-raises-136m-in-debt-restructuring/feed http://pharma-marketer.brollyclient.ca/news-2/roche-pipeline-close-up-will-focus-on-phiii-blockbusters http://pharma-marketer.brollyclient.ca/news-2/roche-pipeline-close-up-will-focus-on-phiii-blockbusters#comments Wed, 17 Mar 2010 17:46:32 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/roche-pipeline-close-up-will-focus-on-phiii-blockbusters http://pharma-marketer.brollyclient.ca/news-2/roche-pipeline-close-up-will-focus-on-phiii-blockbusters/feed http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/theft-at-eli-lilly http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/theft-at-eli-lilly#comments Wed, 17 Mar 2010 17:42:30 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/theft-at-eli-lilly http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/theft-at-eli-lilly/feed http://pharma-marketer.brollyclient.ca/traditional-strategies/should-sanofi-aventis-submit-an-adverse-event-report-based-on-disgruntled-patients-comments-to-voices-fb-page http://pharma-marketer.brollyclient.ca/traditional-strategies/should-sanofi-aventis-submit-an-adverse-event-report-based-on-disgruntled-patients-comments-to-voices-fb-page#comments Wed, 17 Mar 2010 17:21:15 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/should-sanofi-aventis-submit-an-adverse-event-report-based-on-disgruntled-patients-comments-to-voices-fb-page http://pharma-marketer.brollyclient.ca/traditional-strategies/should-sanofi-aventis-submit-an-adverse-event-report-based-on-disgruntled-patients-comments-to-voices-fb-page/feed http://pharma-marketer.brollyclient.ca/news-2/cash-squeeze-triggers-going-concern-alert-at-molecular-insight http://pharma-marketer.brollyclient.ca/news-2/cash-squeeze-triggers-going-concern-alert-at-molecular-insight#comments Wed, 17 Mar 2010 17:06:05 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/cash-squeeze-triggers-going-concern-alert-at-molecular-insight http://pharma-marketer.brollyclient.ca/news-2/cash-squeeze-triggers-going-concern-alert-at-molecular-insight/feed http://pharma-marketer.brollyclient.ca/news-2/clark-johnson-to-become-president-ceo-of-neurologix http://pharma-marketer.brollyclient.ca/news-2/clark-johnson-to-become-president-ceo-of-neurologix#comments Wed, 17 Mar 2010 16:39:52 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/clark-johnson-to-become-president-ceo-of-neurologix Neurologix has tapped Vice Chairman Clark Johnson as its president and CEO to replace John Mordock , who has resigned.]]> http://pharma-marketer.brollyclient.ca/news-2/clark-johnson-to-become-president-ceo-of-neurologix/feed http://pharma-marketer.brollyclient.ca/news-2/hgs-investors-shrug-off-a-mid-stage-cancer-failure http://pharma-marketer.brollyclient.ca/news-2/hgs-investors-shrug-off-a-mid-stage-cancer-failure#comments Wed, 17 Mar 2010 16:29:32 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/hgs-investors-shrug-off-a-mid-stage-cancer-failure http://pharma-marketer.brollyclient.ca/news-2/hgs-investors-shrug-off-a-mid-stage-cancer-failure/feed http://pharma-marketer.brollyclient.ca/regulatory-and-compliance/how-social-media-is-communications-around-public-health-crises http://pharma-marketer.brollyclient.ca/regulatory-and-compliance/how-social-media-is-communications-around-public-health-crises#comments Wed, 17 Mar 2010 16:29:07 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/how-social-media-is-communications-around-public-health-crises http://pharma-marketer.brollyclient.ca/regulatory-and-compliance/how-social-media-is-communications-around-public-health-crises/feed http://pharma-marketer.brollyclient.ca/more/pharma-ads/victoza-%e2%80%93-now-available http://pharma-marketer.brollyclient.ca/more/pharma-ads/victoza-%e2%80%93-now-available#comments Wed, 17 Mar 2010 16:03:05 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/victoza-%e2%80%93-now-available http://pharma-marketer.brollyclient.ca/more/pharma-ads/victoza-%e2%80%93-now-available/feed http://pharma-marketer.brollyclient.ca/news-2/novartis-reports-ph2-success-with-novel-blood-pressure-drug http://pharma-marketer.brollyclient.ca/news-2/novartis-reports-ph2-success-with-novel-blood-pressure-drug#comments Wed, 17 Mar 2010 15:57:18 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/novartis-reports-ph2-success-with-novel-blood-pressure-drug http://pharma-marketer.brollyclient.ca/news-2/novartis-reports-ph2-success-with-novel-blood-pressure-drug/feed http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/biotimes-cellular-aging-results http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/biotimes-cellular-aging-results#comments Wed, 17 Mar 2010 15:28:54 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/biotimes-cellular-aging-results http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/biotimes-cellular-aging-results/feed http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/science-buildings-good-bad-and-weird http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/science-buildings-good-bad-and-weird#comments Wed, 17 Mar 2010 15:16:39 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/science-buildings-good-bad-and-weird http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/science-buildings-good-bad-and-weird/feed http://pharma-marketer.brollyclient.ca/more/pharma-ads/champix-%e2%80%93-champix-can-help-your-mild-to-moderate-copd-patients-stop-smoking http://pharma-marketer.brollyclient.ca/more/pharma-ads/champix-%e2%80%93-champix-can-help-your-mild-to-moderate-copd-patients-stop-smoking#comments Wed, 17 Mar 2010 00:00:39 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/champix-%e2%80%93-champix-can-help-your-mild-to-moderate-copd-patients-stop-smoking http://pharma-marketer.brollyclient.ca/more/pharma-ads/champix-%e2%80%93-champix-can-help-your-mild-to-moderate-copd-patients-stop-smoking/feed http://pharma-marketer.brollyclient.ca/internet-marketing/ehealth-ready-to-move http://pharma-marketer.brollyclient.ca/internet-marketing/ehealth-ready-to-move#comments Tue, 16 Mar 2010 22:43:43 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/ehealth-ready-to-move http://pharma-marketer.brollyclient.ca/internet-marketing/ehealth-ready-to-move/feed http://pharma-marketer.brollyclient.ca/news-2/wyeth-merger-and-federal-legislation-pull-pfizer-in-opposite-directions http://pharma-marketer.brollyclient.ca/news-2/wyeth-merger-and-federal-legislation-pull-pfizer-in-opposite-directions#comments Tue, 16 Mar 2010 22:40:27 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/wyeth-merger-and-federal-legislation-pull-pfizer-in-opposite-directions http://pharma-marketer.brollyclient.ca/news-2/wyeth-merger-and-federal-legislation-pull-pfizer-in-opposite-directions/feed http://pharma-marketer.brollyclient.ca/more/pharma-ads/vyvanse-%e2%80%93-adhd-symptom-control-for-adults http://pharma-marketer.brollyclient.ca/more/pharma-ads/vyvanse-%e2%80%93-adhd-symptom-control-for-adults#comments Tue, 16 Mar 2010 22:24:35 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/vyvanse-%e2%80%93-adhd-symptom-control-for-adults http://pharma-marketer.brollyclient.ca/more/pharma-ads/vyvanse-%e2%80%93-adhd-symptom-control-for-adults/feed http://pharma-marketer.brollyclient.ca/more/pharma-ads/pharmaceutical-vintage-product-packaging http://pharma-marketer.brollyclient.ca/more/pharma-ads/pharmaceutical-vintage-product-packaging#comments Tue, 16 Mar 2010 22:18:04 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/pharmaceutical-vintage-product-packaging http://pharma-marketer.brollyclient.ca/more/pharma-ads/pharmaceutical-vintage-product-packaging/feed http://pharma-marketer.brollyclient.ca/internet-marketing/sanofi-aventis-updates-facebook-site-with-disclaimer-but-shirley-still-posting-about-her-side-effects http://pharma-marketer.brollyclient.ca/internet-marketing/sanofi-aventis-updates-facebook-site-with-disclaimer-but-shirley-still-posting-about-her-side-effects#comments Tue, 16 Mar 2010 21:53:51 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/sanofi-aventis-updates-facebook-site-with-disclaimer-but-shirley-still-posting-about-her-side-effects http://pharma-marketer.brollyclient.ca/internet-marketing/sanofi-aventis-updates-facebook-site-with-disclaimer-but-shirley-still-posting-about-her-side-effects/feed http://pharma-marketer.brollyclient.ca/internet-marketing/yahoos-claim-that-patients-are-ambivalent-when-it-comes-to-side-effect-information-in-search-ads-is-bs http://pharma-marketer.brollyclient.ca/internet-marketing/yahoos-claim-that-patients-are-ambivalent-when-it-comes-to-side-effect-information-in-search-ads-is-bs#comments Tue, 16 Mar 2010 20:30:37 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/yahoos-claim-that-patients-are-ambivalent-when-it-comes-to-side-effect-information-in-search-ads-is-bs http://pharma-marketer.brollyclient.ca/internet-marketing/yahoos-claim-that-patients-are-ambivalent-when-it-comes-to-side-effect-information-in-search-ads-is-bs/feed http://pharma-marketer.brollyclient.ca/more/pharma-ads/antibody-%e2%80%93-top-ten-simple-movements-that-changed-the-world http://pharma-marketer.brollyclient.ca/more/pharma-ads/antibody-%e2%80%93-top-ten-simple-movements-that-changed-the-world#comments Tue, 16 Mar 2010 20:24:26 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/antibody-%e2%80%93-top-ten-simple-movements-that-changed-the-world http://pharma-marketer.brollyclient.ca/more/pharma-ads/antibody-%e2%80%93-top-ten-simple-movements-that-changed-the-world/feed http://pharma-marketer.brollyclient.ca/news-2/biotime-soars-on-cell-aging-reversal http://pharma-marketer.brollyclient.ca/news-2/biotime-soars-on-cell-aging-reversal#comments Tue, 16 Mar 2010 18:08:02 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/biotime-soars-on-cell-aging-reversal http://pharma-marketer.brollyclient.ca/news-2/biotime-soars-on-cell-aging-reversal/feed http://pharma-marketer.brollyclient.ca/more/pharma-ads/zirtek-%e2%80%93-new-zirtek-plus-decongestant http://pharma-marketer.brollyclient.ca/more/pharma-ads/zirtek-%e2%80%93-new-zirtek-plus-decongestant#comments Tue, 16 Mar 2010 18:00:30 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/zirtek-%e2%80%93-new-zirtek-plus-decongestant http://pharma-marketer.brollyclient.ca/more/pharma-ads/zirtek-%e2%80%93-new-zirtek-plus-decongestant/feed http://pharma-marketer.brollyclient.ca/news-2/mannkind-addresses-afrezza-concerns-following-fda-response http://pharma-marketer.brollyclient.ca/news-2/mannkind-addresses-afrezza-concerns-following-fda-response#comments Tue, 16 Mar 2010 18:00:24 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/mannkind-addresses-afrezza-concerns-following-fda-response http://pharma-marketer.brollyclient.ca/news-2/mannkind-addresses-afrezza-concerns-following-fda-response/feed http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/beta-amyloid-an-antibiotic http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/beta-amyloid-an-antibiotic#comments Tue, 16 Mar 2010 17:40:10 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/beta-amyloid-an-antibiotic http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/beta-amyloid-an-antibiotic/feed http://pharma-marketer.brollyclient.ca/news-2/drug-company-ceo-compensation-makes-as-little-sense-this-year-as-it-did-last-year http://pharma-marketer.brollyclient.ca/news-2/drug-company-ceo-compensation-makes-as-little-sense-this-year-as-it-did-last-year#comments Tue, 16 Mar 2010 17:31:28 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/drug-company-ceo-compensation-makes-as-little-sense-this-year-as-it-did-last-year http://pharma-marketer.brollyclient.ca/news-2/drug-company-ceo-compensation-makes-as-little-sense-this-year-as-it-did-last-year/feed http://pharma-marketer.brollyclient.ca/news-2/novartis-no-aliskiren-benefit-in-heart-attacks http://pharma-marketer.brollyclient.ca/news-2/novartis-no-aliskiren-benefit-in-heart-attacks#comments Tue, 16 Mar 2010 17:31:25 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/novartis-no-aliskiren-benefit-in-heart-attacks http://pharma-marketer.brollyclient.ca/news-2/novartis-no-aliskiren-benefit-in-heart-attacks/feed http://pharma-marketer.brollyclient.ca/news-2/sanofi-aventis-pays-15m-to-settle-discrimination-suit http://pharma-marketer.brollyclient.ca/news-2/sanofi-aventis-pays-15m-to-settle-discrimination-suit#comments Tue, 16 Mar 2010 17:31:25 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/sanofi-aventis-pays-15m-to-settle-discrimination-suit http://pharma-marketer.brollyclient.ca/news-2/sanofi-aventis-pays-15m-to-settle-discrimination-suit/feed http://pharma-marketer.brollyclient.ca/internet-marketing/social-pharmer-at-the-2010-e-patient-connections-conference http://pharma-marketer.brollyclient.ca/internet-marketing/social-pharmer-at-the-2010-e-patient-connections-conference#comments Tue, 16 Mar 2010 17:15:18 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/social-pharmer-at-the-2010-e-patient-connections-conference http://pharma-marketer.brollyclient.ca/internet-marketing/social-pharmer-at-the-2010-e-patient-connections-conference/feed http://pharma-marketer.brollyclient.ca/news-2/biotech-vc-funding-leaps-in-4q-as-life-sciences-stays-flat http://pharma-marketer.brollyclient.ca/news-2/biotech-vc-funding-leaps-in-4q-as-life-sciences-stays-flat#comments Tue, 16 Mar 2010 17:11:37 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/biotech-vc-funding-leaps-in-4q-as-life-sciences-stays-flat http://pharma-marketer.brollyclient.ca/news-2/biotech-vc-funding-leaps-in-4q-as-life-sciences-stays-flat/feed http://pharma-marketer.brollyclient.ca/dtc/americas-health-insurance-plans-fights-back-with-full-page-ads http://pharma-marketer.brollyclient.ca/dtc/americas-health-insurance-plans-fights-back-with-full-page-ads#comments Tue, 16 Mar 2010 16:53:44 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/americas-health-insurance-plans-fights-back-with-full-page-ads http://pharma-marketer.brollyclient.ca/dtc/americas-health-insurance-plans-fights-back-with-full-page-ads/feed http://pharma-marketer.brollyclient.ca/regulatory-and-compliance/the-state-of-the-news-media-report-implications-for-pharma-and-fda-part-2 http://pharma-marketer.brollyclient.ca/regulatory-and-compliance/the-state-of-the-news-media-report-implications-for-pharma-and-fda-part-2#comments Tue, 16 Mar 2010 16:37:22 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/the-state-of-the-news-media-report-implications-for-pharma-and-fda-part-2 http://pharma-marketer.brollyclient.ca/regulatory-and-compliance/the-state-of-the-news-media-report-implications-for-pharma-and-fda-part-2/feed http://pharma-marketer.brollyclient.ca/more/pharma-ads/vastarel-%e2%80%93-preserver-le-metabolisme-energetique-du-coeur http://pharma-marketer.brollyclient.ca/more/pharma-ads/vastarel-%e2%80%93-preserver-le-metabolisme-energetique-du-coeur#comments Tue, 16 Mar 2010 16:00:22 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/vastarel-%e2%80%93-preserver-le-metabolisme-energetique-du-coeur http://pharma-marketer.brollyclient.ca/more/pharma-ads/vastarel-%e2%80%93-preserver-le-metabolisme-energetique-du-coeur/feed http://pharma-marketer.brollyclient.ca/news-2/promedior-gains-dutch-vc-backing-in-12m-round http://pharma-marketer.brollyclient.ca/news-2/promedior-gains-dutch-vc-backing-in-12m-round#comments Tue, 16 Mar 2010 15:56:50 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/promedior-gains-dutch-vc-backing-in-12m-round http://pharma-marketer.brollyclient.ca/news-2/promedior-gains-dutch-vc-backing-in-12m-round/feed http://pharma-marketer.brollyclient.ca/news-2/lilly-inks-335m-deal-for-underarm-testosterone-therapy http://pharma-marketer.brollyclient.ca/news-2/lilly-inks-335m-deal-for-underarm-testosterone-therapy#comments Tue, 16 Mar 2010 15:41:07 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/lilly-inks-335m-deal-for-underarm-testosterone-therapy http://pharma-marketer.brollyclient.ca/news-2/lilly-inks-335m-deal-for-underarm-testosterone-therapy/feed http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/terra-incognita http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/terra-incognita#comments Tue, 16 Mar 2010 15:40:30 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/terra-incognita http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/terra-incognita/feed http://pharma-marketer.brollyclient.ca/news-2/out-to-ignite-a-bidding-war-osi-rejects-astellas-bid http://pharma-marketer.brollyclient.ca/news-2/out-to-ignite-a-bidding-war-osi-rejects-astellas-bid#comments Tue, 16 Mar 2010 15:25:52 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/out-to-ignite-a-bidding-war-osi-rejects-astellas-bid http://pharma-marketer.brollyclient.ca/news-2/out-to-ignite-a-bidding-war-osi-rejects-astellas-bid/feed http://pharma-marketer.brollyclient.ca/traditional-strategies/use-of-internet-to-obtain-health-information-can-make-you-depressed http://pharma-marketer.brollyclient.ca/traditional-strategies/use-of-internet-to-obtain-health-information-can-make-you-depressed#comments Tue, 16 Mar 2010 14:33:45 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/use-of-internet-to-obtain-health-information-can-make-you-depressed http://pharma-marketer.brollyclient.ca/traditional-strategies/use-of-internet-to-obtain-health-information-can-make-you-depressed/feed http://pharma-marketer.brollyclient.ca/news-2/pfizer-more-lipitor-cuts-heart-complications-more http://pharma-marketer.brollyclient.ca/news-2/pfizer-more-lipitor-cuts-heart-complications-more#comments Tue, 16 Mar 2010 04:58:15 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/pfizer-more-lipitor-cuts-heart-complications-more http://pharma-marketer.brollyclient.ca/news-2/pfizer-more-lipitor-cuts-heart-complications-more/feed http://pharma-marketer.brollyclient.ca/news-2/a-black-box-warning-for-plavix-confusion-may-follow http://pharma-marketer.brollyclient.ca/news-2/a-black-box-warning-for-plavix-confusion-may-follow#comments Tue, 16 Mar 2010 00:28:58 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/a-black-box-warning-for-plavix-confusion-may-follow http://pharma-marketer.brollyclient.ca/news-2/a-black-box-warning-for-plavix-confusion-may-follow/feed http://pharma-marketer.brollyclient.ca/news-2/impax-challenges-patent-on-abbotts-trilipix http://pharma-marketer.brollyclient.ca/news-2/impax-challenges-patent-on-abbotts-trilipix#comments Tue, 16 Mar 2010 00:28:57 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/impax-challenges-patent-on-abbotts-trilipix http://pharma-marketer.brollyclient.ca/news-2/impax-challenges-patent-on-abbotts-trilipix/feed http://pharma-marketer.brollyclient.ca/news-2/portola-merck-anticoagulant-shows-strong-response http://pharma-marketer.brollyclient.ca/news-2/portola-merck-anticoagulant-shows-strong-response#comments Tue, 16 Mar 2010 00:28:57 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/portola-merck-anticoagulant-shows-strong-response http://pharma-marketer.brollyclient.ca/news-2/portola-merck-anticoagulant-shows-strong-response/feed http://pharma-marketer.brollyclient.ca/news-2/warning-not-all-boxed-warnings-are-equal http://pharma-marketer.brollyclient.ca/news-2/warning-not-all-boxed-warnings-are-equal#comments Tue, 16 Mar 2010 00:28:53 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/warning-not-all-boxed-warnings-are-equal http://pharma-marketer.brollyclient.ca/news-2/warning-not-all-boxed-warnings-are-equal/feed http://pharma-marketer.brollyclient.ca/news-2/what-to-expect-from-fred-hassan-at-bausch-lomb http://pharma-marketer.brollyclient.ca/news-2/what-to-expect-from-fred-hassan-at-bausch-lomb#comments Tue, 16 Mar 2010 00:28:52 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/what-to-expect-from-fred-hassan-at-bausch-lomb http://pharma-marketer.brollyclient.ca/news-2/what-to-expect-from-fred-hassan-at-bausch-lomb/feed http://pharma-marketer.brollyclient.ca/more/pharma-ads/boom-%e2%80%93-in-2010-the-world-goes-boom http://pharma-marketer.brollyclient.ca/more/pharma-ads/boom-%e2%80%93-in-2010-the-world-goes-boom#comments Mon, 15 Mar 2010 22:48:08 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/boom-%e2%80%93-in-2010-the-world-goes-boom http://pharma-marketer.brollyclient.ca/more/pharma-ads/boom-%e2%80%93-in-2010-the-world-goes-boom/feed http://pharma-marketer.brollyclient.ca/dtc/patient-testimonials-via-social-media-does-the-fda-need-to-protect-patients-from-themselves http://pharma-marketer.brollyclient.ca/dtc/patient-testimonials-via-social-media-does-the-fda-need-to-protect-patients-from-themselves#comments Mon, 15 Mar 2010 22:46:51 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/patient-testimonials-via-social-media-does-the-fda-need-to-protect-patients-from-themselves http://pharma-marketer.brollyclient.ca/dtc/patient-testimonials-via-social-media-does-the-fda-need-to-protect-patients-from-themselves/feed http://pharma-marketer.brollyclient.ca/news-2/4-star-stocks-poised-to-pop-3sbio http://pharma-marketer.brollyclient.ca/news-2/4-star-stocks-poised-to-pop-3sbio#comments Mon, 15 Mar 2010 22:02:04 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/4-star-stocks-poised-to-pop-3sbio http://pharma-marketer.brollyclient.ca/news-2/4-star-stocks-poised-to-pop-3sbio/feed http://pharma-marketer.brollyclient.ca/news-2/novartis-heart-diabetes-drugs-fail-to-prevent-disease-in-study http://pharma-marketer.brollyclient.ca/news-2/novartis-heart-diabetes-drugs-fail-to-prevent-disease-in-study#comments Mon, 15 Mar 2010 22:02:04 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/novartis-heart-diabetes-drugs-fail-to-prevent-disease-in-study http://pharma-marketer.brollyclient.ca/news-2/novartis-heart-diabetes-drugs-fail-to-prevent-disease-in-study/feed http://pharma-marketer.brollyclient.ca/news-2/elan-sticks-it-to-shareholders-with-jj-deal http://pharma-marketer.brollyclient.ca/news-2/elan-sticks-it-to-shareholders-with-jj-deal#comments Mon, 15 Mar 2010 22:02:03 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/elan-sticks-it-to-shareholders-with-jj-deal http://pharma-marketer.brollyclient.ca/news-2/elan-sticks-it-to-shareholders-with-jj-deal/feed http://pharma-marketer.brollyclient.ca/news-2/fred-hassan-finds-new-perch http://pharma-marketer.brollyclient.ca/news-2/fred-hassan-finds-new-perch#comments Mon, 15 Mar 2010 22:02:02 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/fred-hassan-finds-new-perch http://pharma-marketer.brollyclient.ca/news-2/fred-hassan-finds-new-perch/feed http://pharma-marketer.brollyclient.ca/news-2/roche-pfizer-cancer-meds-fail-trials http://pharma-marketer.brollyclient.ca/news-2/roche-pfizer-cancer-meds-fail-trials#comments Mon, 15 Mar 2010 22:02:02 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/roche-pfizer-cancer-meds-fail-trials http://pharma-marketer.brollyclient.ca/news-2/roche-pfizer-cancer-meds-fail-trials/feed http://pharma-marketer.brollyclient.ca/more/pharma-ads/lexapro-%e2%80%93-so-many-symptoms%e2%80%a6 http://pharma-marketer.brollyclient.ca/more/pharma-ads/lexapro-%e2%80%93-so-many-symptoms%e2%80%a6#comments Mon, 15 Mar 2010 20:48:04 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/lexapro-%e2%80%93-so-many-symptoms%e2%80%a6 http://pharma-marketer.brollyclient.ca/more/pharma-ads/lexapro-%e2%80%93-so-many-symptoms%e2%80%a6/feed http://pharma-marketer.brollyclient.ca/internet-marketing/why-cataloging-and-calculations-should-be-king http://pharma-marketer.brollyclient.ca/internet-marketing/why-cataloging-and-calculations-should-be-king#comments Mon, 15 Mar 2010 19:34:54 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/why-cataloging-and-calculations-should-be-king http://pharma-marketer.brollyclient.ca/internet-marketing/why-cataloging-and-calculations-should-be-king/feed http://pharma-marketer.brollyclient.ca/news-2/sigma-aldrich-to-sell-pfizer-developed-compounds http://pharma-marketer.brollyclient.ca/news-2/sigma-aldrich-to-sell-pfizer-developed-compounds#comments Mon, 15 Mar 2010 19:17:07 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/sigma-aldrich-to-sell-pfizer-developed-compounds http://pharma-marketer.brollyclient.ca/news-2/sigma-aldrich-to-sell-pfizer-developed-compounds/feed http://pharma-marketer.brollyclient.ca/news-2/study-abbott-mini-clip-is-safer-than-heart-valve-surgery http://pharma-marketer.brollyclient.ca/news-2/study-abbott-mini-clip-is-safer-than-heart-valve-surgery#comments Mon, 15 Mar 2010 19:17:05 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/study-abbott-mini-clip-is-safer-than-heart-valve-surgery http://pharma-marketer.brollyclient.ca/news-2/study-abbott-mini-clip-is-safer-than-heart-valve-surgery/feed http://pharma-marketer.brollyclient.ca/news-2/osi-ceo-goddard-rejects-astellas-on-tarceva-7-billion-promise http://pharma-marketer.brollyclient.ca/news-2/osi-ceo-goddard-rejects-astellas-on-tarceva-7-billion-promise#comments Mon, 15 Mar 2010 19:17:05 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/osi-ceo-goddard-rejects-astellas-on-tarceva-7-billion-promise http://pharma-marketer.brollyclient.ca/news-2/osi-ceo-goddard-rejects-astellas-on-tarceva-7-billion-promise/feed http://pharma-marketer.brollyclient.ca/news-2/mannkinda%c2%80%c2%99s-insulin-afrezza-fails-to-win-approval http://pharma-marketer.brollyclient.ca/news-2/mannkinda%c2%80%c2%99s-insulin-afrezza-fails-to-win-approval#comments Mon, 15 Mar 2010 19:17:04 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/mannkinda%c2%80%c2%99s-insulin-afrezza-fails-to-win-approval http://pharma-marketer.brollyclient.ca/news-2/mannkinda%c2%80%c2%99s-insulin-afrezza-fails-to-win-approval/feed http://pharma-marketer.brollyclient.ca/news-2/mercks-troubled-cholesterol-drug-vytorin-awaits-rescue-three-years-too-late http://pharma-marketer.brollyclient.ca/news-2/mercks-troubled-cholesterol-drug-vytorin-awaits-rescue-three-years-too-late#comments Mon, 15 Mar 2010 19:17:03 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/mercks-troubled-cholesterol-drug-vytorin-awaits-rescue-three-years-too-late http://pharma-marketer.brollyclient.ca/news-2/mercks-troubled-cholesterol-drug-vytorin-awaits-rescue-three-years-too-late/feed http://pharma-marketer.brollyclient.ca/regulatory-and-compliance/the-state-of-the-news-media-report-implications-for-pharma-and-fda-part-1 http://pharma-marketer.brollyclient.ca/regulatory-and-compliance/the-state-of-the-news-media-report-implications-for-pharma-and-fda-part-1#comments Mon, 15 Mar 2010 19:14:11 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/the-state-of-the-news-media-report-implications-for-pharma-and-fda-part-1 http://pharma-marketer.brollyclient.ca/regulatory-and-compliance/the-state-of-the-news-media-report-implications-for-pharma-and-fda-part-1/feed http://pharma-marketer.brollyclient.ca/news-2/ngm-lands-51m-for-preclinical-diabetes-work http://pharma-marketer.brollyclient.ca/news-2/ngm-lands-51m-for-preclinical-diabetes-work#comments Mon, 15 Mar 2010 18:41:10 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/ngm-lands-51m-for-preclinical-diabetes-work http://pharma-marketer.brollyclient.ca/news-2/ngm-lands-51m-for-preclinical-diabetes-work/feed http://pharma-marketer.brollyclient.ca/news-2/inspire-azasite-doesnt-meet-goals-in-trials http://pharma-marketer.brollyclient.ca/news-2/inspire-azasite-doesnt-meet-goals-in-trials#comments Mon, 15 Mar 2010 18:20:58 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/inspire-azasite-doesnt-meet-goals-in-trials http://pharma-marketer.brollyclient.ca/news-2/inspire-azasite-doesnt-meet-goals-in-trials/feed http://pharma-marketer.brollyclient.ca/more/pharma-ads/medtronic-%e2%80%93-nothing http://pharma-marketer.brollyclient.ca/more/pharma-ads/medtronic-%e2%80%93-nothing#comments Mon, 15 Mar 2010 18:00:23 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/medtronic-%e2%80%93-nothing http://pharma-marketer.brollyclient.ca/more/pharma-ads/medtronic-%e2%80%93-nothing/feed http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/stem-cell-politics http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/stem-cell-politics#comments Mon, 15 Mar 2010 17:25:24 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/stem-cell-politics http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/stem-cell-politics/feed http://pharma-marketer.brollyclient.ca/more/pharma-ads/movicol-%e2%80%93-it-works-stimulate-lubricate-bulk-soften-4-kids http://pharma-marketer.brollyclient.ca/more/pharma-ads/movicol-%e2%80%93-it-works-stimulate-lubricate-bulk-soften-4-kids#comments Mon, 15 Mar 2010 17:02:08 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/movicol-%e2%80%93-it-works-stimulate-lubricate-bulk-soften-4-kids http://pharma-marketer.brollyclient.ca/more/pharma-ads/movicol-%e2%80%93-it-works-stimulate-lubricate-bulk-soften-4-kids/feed http://pharma-marketer.brollyclient.ca/news-2/mannkinds-inhaled-insulin-drug-afrezza-delayed http://pharma-marketer.brollyclient.ca/news-2/mannkinds-inhaled-insulin-drug-afrezza-delayed#comments Mon, 15 Mar 2010 16:45:57 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/mannkinds-inhaled-insulin-drug-afrezza-delayed http://pharma-marketer.brollyclient.ca/news-2/mannkinds-inhaled-insulin-drug-afrezza-delayed/feed http://pharma-marketer.brollyclient.ca/news-2/fda-delays-amylins-byetta-lar http://pharma-marketer.brollyclient.ca/news-2/fda-delays-amylins-byetta-lar#comments Mon, 15 Mar 2010 16:21:22 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/fda-delays-amylins-byetta-lar http://pharma-marketer.brollyclient.ca/news-2/fda-delays-amylins-byetta-lar/feed http://pharma-marketer.brollyclient.ca/dtc/how-to-earn-back-trust-with-a-very-skeptical-audience http://pharma-marketer.brollyclient.ca/dtc/how-to-earn-back-trust-with-a-very-skeptical-audience#comments Mon, 15 Mar 2010 16:19:03 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/how-to-earn-back-trust-with-a-very-skeptical-audience http://pharma-marketer.brollyclient.ca/dtc/how-to-earn-back-trust-with-a-very-skeptical-audience/feed http://pharma-marketer.brollyclient.ca/traditional-strategies/disgruntled-patient-shuts-down-sanofi-aventis-facebook-page http://pharma-marketer.brollyclient.ca/traditional-strategies/disgruntled-patient-shuts-down-sanofi-aventis-facebook-page#comments Mon, 15 Mar 2010 16:00:09 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/disgruntled-patient-shuts-down-sanofi-aventis-facebook-page http://pharma-marketer.brollyclient.ca/traditional-strategies/disgruntled-patient-shuts-down-sanofi-aventis-facebook-page/feed http://pharma-marketer.brollyclient.ca/news-2/portola-merck-report-postitive-betrixaban-results http://pharma-marketer.brollyclient.ca/news-2/portola-merck-report-postitive-betrixaban-results#comments Mon, 15 Mar 2010 15:53:23 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/portola-merck-report-postitive-betrixaban-results http://pharma-marketer.brollyclient.ca/news-2/portola-merck-report-postitive-betrixaban-results/feed http://pharma-marketer.brollyclient.ca/news-2/rhythm-pharma-raises-21m-for-metabolic-diseases http://pharma-marketer.brollyclient.ca/news-2/rhythm-pharma-raises-21m-for-metabolic-diseases#comments Mon, 15 Mar 2010 15:45:58 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/rhythm-pharma-raises-21m-for-metabolic-diseases http://pharma-marketer.brollyclient.ca/news-2/rhythm-pharma-raises-21m-for-metabolic-diseases/feed http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/tricors-troubles http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/tricors-troubles#comments Mon, 15 Mar 2010 15:22:13 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/tricors-troubles http://pharma-marketer.brollyclient.ca/more/in-the-pipeline/tricors-troubles/feed http://pharma-marketer.brollyclient.ca/more/pharma-ads/ebixa-%e2%80%93-you-can-make-a-difference-sooner-with-ebixa http://pharma-marketer.brollyclient.ca/more/pharma-ads/ebixa-%e2%80%93-you-can-make-a-difference-sooner-with-ebixa#comments Mon, 15 Mar 2010 14:30:48 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/ebixa-%e2%80%93-you-can-make-a-difference-sooner-with-ebixa http://pharma-marketer.brollyclient.ca/more/pharma-ads/ebixa-%e2%80%93-you-can-make-a-difference-sooner-with-ebixa/feed http://pharma-marketer.brollyclient.ca/dtc/building-a-great-online-experience-for-a-health-website http://pharma-marketer.brollyclient.ca/dtc/building-a-great-online-experience-for-a-health-website#comments Sun, 14 Mar 2010 17:31:59 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/building-a-great-online-experience-for-a-health-website http://pharma-marketer.brollyclient.ca/dtc/building-a-great-online-experience-for-a-health-website/feed http://pharma-marketer.brollyclient.ca/news-2/ligand-announces-approval-for-revolade-in-europe http://pharma-marketer.brollyclient.ca/news-2/ligand-announces-approval-for-revolade-in-europe#comments Sun, 14 Mar 2010 05:32:04 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/ligand-announces-approval-for-revolade-in-europe http://pharma-marketer.brollyclient.ca/news-2/ligand-announces-approval-for-revolade-in-europe/feed http://pharma-marketer.brollyclient.ca/news-2/pfizer-failsa%c2%80%c2%a6-again http://pharma-marketer.brollyclient.ca/news-2/pfizer-failsa%c2%80%c2%a6-again#comments Sun, 14 Mar 2010 03:22:05 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/pfizer-failsa%c2%80%c2%a6-again http://pharma-marketer.brollyclient.ca/news-2/pfizer-failsa%c2%80%c2%a6-again/feed http://pharma-marketer.brollyclient.ca/news-2/oncothyreon-to-restate-financial-statements http://pharma-marketer.brollyclient.ca/news-2/oncothyreon-to-restate-financial-statements#comments Sun, 14 Mar 2010 03:22:05 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/oncothyreon-to-restate-financial-statements http://pharma-marketer.brollyclient.ca/news-2/oncothyreon-to-restate-financial-statements/feed http://pharma-marketer.brollyclient.ca/news-2/obagi-4q-profit-doubles-on-skin-product-sales http://pharma-marketer.brollyclient.ca/news-2/obagi-4q-profit-doubles-on-skin-product-sales#comments Sun, 14 Mar 2010 03:22:04 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/obagi-4q-profit-doubles-on-skin-product-sales http://pharma-marketer.brollyclient.ca/news-2/obagi-4q-profit-doubles-on-skin-product-sales/feed http://pharma-marketer.brollyclient.ca/news-2/optimer-pharma-reports-narrower-4th-quarter-loss http://pharma-marketer.brollyclient.ca/news-2/optimer-pharma-reports-narrower-4th-quarter-loss#comments Sun, 14 Mar 2010 03:22:03 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/optimer-pharma-reports-narrower-4th-quarter-loss http://pharma-marketer.brollyclient.ca/news-2/optimer-pharma-reports-narrower-4th-quarter-loss/feed http://pharma-marketer.brollyclient.ca/news-2/abbott-shares-dip-analyst-sees-profit-concerns http://pharma-marketer.brollyclient.ca/news-2/abbott-shares-dip-analyst-sees-profit-concerns#comments Sun, 14 Mar 2010 03:22:03 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/abbott-shares-dip-analyst-sees-profit-concerns http://pharma-marketer.brollyclient.ca/news-2/abbott-shares-dip-analyst-sees-profit-concerns/feed http://pharma-marketer.brollyclient.ca/news-2/genvec-shares-rise-on-narrower-4th-quarter-loss http://pharma-marketer.brollyclient.ca/news-2/genvec-shares-rise-on-narrower-4th-quarter-loss#comments Sun, 14 Mar 2010 01:11:08 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/genvec-shares-rise-on-narrower-4th-quarter-loss http://pharma-marketer.brollyclient.ca/news-2/genvec-shares-rise-on-narrower-4th-quarter-loss/feed http://pharma-marketer.brollyclient.ca/news-2/brower-piven-encourages-investors-who-have-losses-in-excess-of-50000-from-investment-in-novelos-therapeutics-inc-to http://pharma-marketer.brollyclient.ca/news-2/brower-piven-encourages-investors-who-have-losses-in-excess-of-50000-from-investment-in-novelos-therapeutics-inc-to#comments Sun, 14 Mar 2010 01:11:07 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/brower-piven-encourages-investors-who-have-losses-in-excess-of-50000-from-investment-in-novelos-therapeutics-inc-to http://pharma-marketer.brollyclient.ca/news-2/brower-piven-encourages-investors-who-have-losses-in-excess-of-50000-from-investment-in-novelos-therapeutics-inc-to/feed http://pharma-marketer.brollyclient.ca/news-2/genzyme-discloses-contamination-at-ireland-plant http://pharma-marketer.brollyclient.ca/news-2/genzyme-discloses-contamination-at-ireland-plant#comments Sun, 14 Mar 2010 01:11:06 +0000 Pharma Marketer http://pharma-marketer.brollyclient.ca/news-2/genzyme-discloses-contamination-at-ireland-plant http://pharma-marketer.brollyclient.ca/news-2/genzyme-discloses-contamination-at-ireland-plant/feed